Publication | Closed Access

Synergistic treatment of ovarian cancer by co-delivery of survivin shRNA and paclitaxel via supramolecular micellar assembly

NanomedicineEngineeringSupramolecular Micellar AssemblyNano-drug DeliveryTumor TargetingGene DeliveryBiomedical EngineeringMedicineSurvivin ShrnaTumor BiologyBiomolecular EngineeringOvarian Cancer